13F

Investor

GENERAL ATLANTIC, L.P.

CIK 0001017645 · filed 2026-05-15 · SEC filing

13F book

$2.15B

Positions

12

0 new · 1 sold

Largest name

28.2%

Dlocal Ltd · DLO

Est. mark

−$179.9M

Price effect on 12 names still held. Flow −$544.4M.
NameTickerSharesValueWeightEst. markChange
Dlocal LtdDLO46.7M$605.1M28.2%−$54.6MHeld
Chime Finl Inc21.3M$398.2M18.5%−$136.9MHeld
XP Inc.XP20.6M$391.6M18.2%$54.9MCut$20M
Alkami Technology, Inc.ALKT15.3M$240.3M11.2%−$88.7MAdded−$36.3M
Pharvaris N.V.PHVS8.03M$226.9M10.6%$4.02MHeld
European Wax Ctr Inc13.1M$75.8M3.5%$28.6MHeld
Revolution Medicines Inc707.8K$68.8M3.2%$12.5MCut−$155.2M
Nurix Therapeutics, Inc.NRIX4.1M$63.6M3.0%−$14.2MCut−$29.3M
Centessa Pharmaceuticals Plc1.35M$53.8M2.5%$19.9MCut−$99.2M
Riskified Ltd.RSKD5.32M$20.9M1.0%−$5.59MHeld
Grove Collaborative Hold Inc2.47M$3.17M0.1%$445.5KHeld
Webull Corp50.8K$243.9K0.0%−$150.9KHeld

Positions as of Q1 2026. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.